Works by Jiang, Guozhong


Results: 28
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 8, p. 1648, doi. 10.1002/ijc.34372
    By:
    • Jin, Shuiling;
    • Zhao, Ruihua;
    • Zhou, Chuang;
    • Zhong, Qian;
    • Shi, Jianxiang;
    • Su, Chang;
    • Li, Qinglong;
    • Su, Xiaoxing;
    • Chi, Huabin;
    • Lu, Xu;
    • Jiang, Guozhong;
    • Chen, Renyin;
    • Han, Jinming;
    • Jiang, Miao;
    • Qiao, Shishi;
    • Liu, Jingjing;
    • Song, Min;
    • Song, Lijie;
    • Du, Yabing;
    • Chang, Zhiwei
    Publication type:
    Article
    22
    23
    24
    25

    Potent and specific MTH1 inhibitors targeting gastric cancer.

    Published in:
    Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1665-3
    By:
    • Zhou, Wenjuan;
    • Ma, Liying;
    • Yang, Jing;
    • Qiao, Hui;
    • Li, Lingyu;
    • Guo, Qian;
    • Ma, Jinlian;
    • Zhao, Lijuan;
    • Wang, Junwei;
    • Jiang, Guozhong;
    • Wan, Xiangbin;
    • Adam Goscinski, Mariusz;
    • Ding, Lina;
    • Zheng, Yichao;
    • Li, Wencai;
    • Liu, Hongmin;
    • Suo, Zhenhe;
    • Zhao, Wen
    Publication type:
    Article
    26
    27
    28